SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-22-014659
Filing Date
2022-09-27
Accepted
2022-09-27 17:20:27
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20220927xdefa14a.htm DEFA14A 13730
2 GRAPHIC tmb-20220927xdefa14a001.jpg GRAPHIC 6221
  Complete submission text file 0001558370-22-014659.txt   23740
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-38247 | Film No.: 221272149
SIC: 2834 Pharmaceutical Preparations